Angiotensinogen Antisense Oligonucleotides and Fluid Intake

References

• Bickerton R. K., Buckley J. P. Evidence for a central mechanism of angiotensin induced hypertension. Proc Soc Exp Biol Med. 1961; 106: 834–837
   Web of Science ®Google Scholar
• Brosnihan K. B., Diz D. I., Schiavone M. T., Averill D. B., Ferrario C. M. Approaches to establishing angiotensin II as a neurotransmitter. Brain Peptides and Catecholamines in Cardiovascular Regulation, J. P. Buckley, C. M. Ferrario. Raven Press, New York 1987; 313–328
   Google Scholar
• Chiang M. Y., Chan H., Zounes M. A., Freier S. M., Lima W. F., Bennett C. F. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J Biol Chem. 1991; 266: 18162–18171
   PubMed Web of Science ®Google Scholar
• Chiasson B. J., Hooper M. L., Murphy P. R., Robertson H. A. Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain. Eur J Pharmacol. 1992; 227: 451–453
   PubMed Web of Science ®Google Scholar
• Clemens D. L., Clauser E., Celio M. R., Inagami I. T. Generation of angiotensinogen by cultural neuroblastoma and glioma cells. Brain Res. 1986; 364: 205–211
   PubMed Web of Science ®Google Scholar
• Deschepper C. F., Bouhnik J., Ganong W. F. Colocalization of angiotensinogen and glial fibrillary acidic protein in astrocytes in rat brain. Brain Res. 1986; 374: 195–198
   PubMed Web of Science ®Google Scholar
• Epstein A. N., Fitzsimons J. T., Rolls B. J. Drinking induced by injection of angiotensin into the brain of the rat. J Physiol. 1970; 210: 457–474
   PubMed Web of Science ®Google Scholar
• Fernley R. T., John M., Niall H. D., Coghlan J. P. Purification and characterization of ovine angiotensinogen. Eur J Biochem. 1986; 154(3)597–601
   PubMedGoogle Scholar
• Fitts D. A. Angiotensin II receptors in SFO but not in OVLT mediate isoproterenol-induced thirst. Am J Physiol. 1994; 267(1 Pt 2)R7–R15
   Google Scholar
• Fitzsimons J. T., Stricker E. M. Sodium Appetite and the renin-angiotensin system. Nature, New Biology 1971; 231: 58–60
   PubMedGoogle Scholar
• Fregly M. J., Rowland N. E. Effect of DuP 753, a nonpeptide angiotensin II receptor antagonist, on the drinking responses to acutely administered dipsogenic agents in rats. P. S. E. B. M. 1992; 199: 158–164
   PubMed Web of Science ®Google Scholar
• Gyurko R., Weilbo D., Phillips M. I. Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul Pept. 1993; 49: 167–174
   PubMed Web of Science ®Google Scholar
• Heidenreich O., Kang S. H., Xu X., Nerenberg M. Application of antisense technology to therapeutics. Molecular Medicine Today. 1995; 1: 128–133
   PubMedGoogle Scholar
• Hooper M. L., Chiasson B. J., Robertson H. A. Infusion into the brain of an antisense oligonucleotide to the immediate-early gene c-fos suppresses production of Fos and produces behavioral effect. Neurosci. 1994; 63: 917–924
   PubMed Web of Science ®Google Scholar
• Hosutt J. A., Rowland N., Stricker E. M. Hypotension and thirst in rats after isoproterenol treatment. Physiol Behav. 1978; 21(4)593–598
   PubMed Web of Science ®Google Scholar
• Houpt K, Epstein A. N. The complete dependence of beta-adrenergic drinking on the renal dipsogen. Physiol Behav. 1971; 7: 897–902
   PubMed Web of Science ®Google Scholar
• Joy M. D., Lowe R. D. Site of cardiovascular action of angiotensin II in the brain. Clin. Sciences 1970; 39: 327–336
   PubMed Web of Science ®Google Scholar
• Katovich M. J., Barney C. C., Fregly M. J., McCaa R. E. Effect of an angiotensin converting enzyme inhibitor (SQ 14,225) on betaadrenergic and angiotensin-induced thirsts. Eur J Pharmacol. 1979; 56: 123–130
   PubMed Web of Science ®Google Scholar
• Leenen F. H.H., Stricker E. M., McDonald R. H., De Jong W. Relationship between increase in plasma renin activity and drinking following different types of dipsogenic stimuli. Control Mechanisms of Drinking, G. Peters, J. T. Fitzsimons, L. Peters-Haefeli. Springer Verlag, Berlin 1975; 84–88
   Google Scholar
• Lind R. W. Sites of action of angiotensin in the brain. Angiotensin and blood pressure regulation, J. W. Harding, J. W. Wright, R. C. Speth, C. D. Barnes. Academic Press, San Diego 1988; 135–163
   Google Scholar
• Lind R. W., Swanson L. W., Ganten D. Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system. Neuroendocrinology 1985; 40: 2–24
   PubMed Web of Science ®Google Scholar
• Lynch K. R., Hawelu-Johnson C. L., Guyenet P. G. Localization of brain angiotensinogen mRNA by hybridization histochemistry. Molecular Brain Res. 1987; 2: 149–158
   Google Scholar
• Mann J. F.E., Johnson A. K., Ganten D. Plasma angiotensin II: Dipsogenic levels and angiotensin-generating capacity of renin. Am J Physiol. 1980; 238: R372–R377
   PubMed Web of Science ®Google Scholar
• McKinley M. J., Coghlan J. P., Congiu M., Denton D. A., Fei D. T., Park R. G. Augmented plasma renin levels in dehydrated sheep with periventricular lesions. Brain Res. 1986; 376: 416–419
   PubMed Web of Science ®Google Scholar
• McKinley M. J., Rundgren M., Coghlan J. P. Cerebral osmoregulatory reduction of plasma renin concentration in sheep. Acta Physiol Scand. 1994; 152: 323–332
   PubMedGoogle Scholar
• Milligan J. F., Matteucci M. D., Martin J. C. Current concepts in antisense drug design. J Medicinal Chem. 1993; 36(14)1923–1937
   PubMed Web of Science ®Google Scholar
• Ohkubo H., Kageyama R., Ujihara M., Hirose T., Inayama S., Nakanishi S. Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci U.S.A. 1983; 80: 2196–2200
   PubMed Web of Science ®Google Scholar
• Paxinos G., Watson C. The Rat Brain in Stereotaxic. Coordinates Academic, New York 1982
   Google Scholar
• Pilowsky P. M., Suzuki S., Minson J. B. Antisense oligonucleotides: a new tool in neuroscience. Clin Exper Pharmacol Physiol. 1994; 21: 935–944
   PubMed Web of Science ®Google Scholar
• Robinson M., Evered M. D. Angiotensin and the arterial pressure in the control of thirst. The Physiology of Thirst, G. de Caro, A. N. Epstein, M. Massi. Plenum Press, New York 1986; 193–198
   Google Scholar
• Scammell J. C., Fregly M. J. Attenuation of isoproterenol-stimulated plasma renin activity by chronic estrogen treatment. Proc Soc Exp Biol Med. 1981; 167: 117–121
   PubMed Web of Science ®Google Scholar
• Simpson J. B. The circumventricular organs and the central actions of angiotensin. Neuroendocrinology 1980; 32: 248–256
   Web of Science ®Google Scholar
• Stein C. A., Subasinghe C., Shinozuka K., Cohen J. S. Physicochemical properties of phosphorothioate oligonucleotides. Nucl Acids Res. 1988; 16: 3209–3221
   PubMed Web of Science ®Google Scholar
• Stornetta R. L., Hawelu-Johnson C. L., Guyenet P. G., Lynch K. R. Astrocytes synthesise angiotensinogen in brain. Science 1988; 242: 1444–1446
   PubMed Web of Science ®Google Scholar
• Stricker E. M. The renin-angiotensin system and thirst: A reevaluation. II. Drinking elicited in rats by caval ligation or isoproterenol. J Comp Physiol Psychol. 1977; 91: 1220–1231
   PubMed Web of Science ®Google Scholar
• Stull R. A., Taylor L. A., Szoka J. C., Jr. Predicting antisense oligonucleotide inhibitory efficacy: A computational approach using histograms and thermodynamic indices. Nucl Acids Res. 1992; 20: 3501–3508
   PubMed Web of Science ®Google Scholar
• Suzuki S., Pilowsky P., Minson J., Arnolda L., Smith I. J.L., Chalmers J. c-Fos antisense in rostral ventral medulla reduces arterial blood pressure. Am J Physiol. 1994; 266: R1418–1422
   Google Scholar
• Van Der Krol A. R., Mol J. N.M., Stuitje A. R. Modulation of eukaryotic gene expression by complementary RNA or DNA sequences. Biotechniques 1988; 6: 958–976
   PubMed Web of Science ®Google Scholar
• Wahlstedt D., Pic H. E.M., Koob G. M., Yee F., Heilig M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligonucleotides, Science 1993; 259: 528–531
   Google Scholar
• Weilbo D., Sernia C., Gyurko R., Phillips I. M. Antisense inhibition of hypertension in the spontaneously hypertensive rat. Hypertension 1995; 25: 314–319
   PubMed Web of Science ®Google Scholar
• Zon G. Brief overview of Genetic Expression by antisense oligonucleotides and In vivo applications. Molecular Neurobiology 1995; 10(2-3)219–22
   PubMed Web of Science ®Google Scholar